Quantum Biopharma Share Holder Equity 2019-2024 | QNTM

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Quantum Biopharma share holder equity from 2019 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Quantum Biopharma share holder equity from 2019 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Amgen (AMGN)	$171.6B
Vertex Pharmaceuticals (VRTX)	$129B
Bristol Myers Squibb (BMY)	$113.5B
Gilead Sciences (GILD)	$112.3B
CSL (CSLLY)	$91.7B
Regeneron Pharmaceuticals (REGN)	$91.1B
GSK (GSK)	$76.7B
Argenex SE (ARGX)	$36B
Alnylam Pharmaceuticals (ALNY)	$34.2B
BioNTech SE (BNTX)	$26.4B
Biogen (BIIB)	$25.8B
Illumina (ILMN)	$24.7B
Moderna (MRNA)	$20.5B
BeiGene (BGNE)	$20.3B
Genmab (GMAB)	$15.1B
Incyte (INCY)	$14.9B
Exact Sciences (EXAS)	$13.2B
BioMarin Pharmaceutical (BMRN)	$12.6B
Insmed (INSM)	$12.4B
Bio-Techne Corp (TECH)	$12.3B
Vaxcyte (PCVX)	$12B
Sarepta Therapeutics (SRPT)	$11.9B
QIAGEN (QGEN)	$10B
Exelixis (EXEL)	$9.9B
Revolution Medicines (RVMD)	$9.5B
Intra-Cellular Therapies (ITCI)	$9.5B
Bio-Rad Laboratories (BIO.B)	$9.4B
Roivant Sciences (ROIV)	$8.6B
Repligen (RGEN)	$8.2B
Legend Biotech (LEGN)	$8.1B